BioCentury | Sep 3, 2009
Distillery Therapeutics

Indication: Inflammation

Indication Target/marker/pathway Summary Licensing status Publication and contact information Inflammation Inflammation p38 mitogen-activated protein kinase (MAPK14; p38 MAPK) In vitro and rodent studies identified aminopyridine N-oxide inhibitors of MAPK14 that could help treat inflammation. In...
BioCentury | Mar 31, 2008
Company News

Lumera, GigOptix LLC deal

...focus on the electro-optic space. Lumera will divest its Plexera Bioscience LLC subsidiary, a CRO. Lumera Corp....
BioCentury | Feb 4, 2008
Company News

Auguron Biosciences Inc., Lumera deal

...screening compounds and vaccines. Financial terms were not disclosed. Auguron Biosciences Inc. , Cambridge, Mass. Lumera Corp....
BioCentury | Oct 1, 2007
Company News

Lumera, Mitosciences deal

...University of South Carolina are building mitochondrial antibody assays for LMRA (see BioCentury, May 7). Lumera Corp....
BioCentury | Aug 20, 2007
Company News

Lumera management update

Lumera Corp. (LMRA), Bothell, Wash. Business: Supply/Service, Microarrays Resigned: Tom Mino as CEO and a director; Joseph Vallner, a director, will become interim CEO and president WIR Staff...
BioCentury | Aug 13, 2007
Company News

Capnia management update

...as SVP of technology development Departed: CEO Joseph Vallner to become chairman and CEO of Lumera Corp....
BioCentury | Aug 7, 2007
Company News

Capnia names Mario CEO

...replaces Joseph Vallner, who departed to become chairman and CEO of the Plexera subsidiary of Lumera...
BioCentury | Jul 23, 2007
Company News

Lumera supply/service, microarrays news

...be promoted to president and COO of Plexara from director of the bioscience business unit. Lumera Corp....
BioCentury | May 7, 2007
Company News

Lumera, Medical University of South Carolina deal

...of mitochondrial proteins. LMRA has rights to commercialize resulting IP. Financial terms were not disclosed. Lumera Corp....
BioCentury | Mar 12, 2007
Company News

Lumera board of directors update

Lumera Corp. (LMRA), Bothell, Wash. Business: Supply/Service, Microarrays Appointed: C. James Judson, a director, as chairman; he replaces Bob Ratliffe, who will remain a director WIR Staff...
Items per page:
1 - 10 of 21
BioCentury | Sep 3, 2009
Distillery Therapeutics

Indication: Inflammation

Indication Target/marker/pathway Summary Licensing status Publication and contact information Inflammation Inflammation p38 mitogen-activated protein kinase (MAPK14; p38 MAPK) In vitro and rodent studies identified aminopyridine N-oxide inhibitors of MAPK14 that could help treat inflammation. In...
BioCentury | Mar 31, 2008
Company News

Lumera, GigOptix LLC deal

...focus on the electro-optic space. Lumera will divest its Plexera Bioscience LLC subsidiary, a CRO. Lumera Corp....
BioCentury | Feb 4, 2008
Company News

Auguron Biosciences Inc., Lumera deal

...screening compounds and vaccines. Financial terms were not disclosed. Auguron Biosciences Inc. , Cambridge, Mass. Lumera Corp....
BioCentury | Oct 1, 2007
Company News

Lumera, Mitosciences deal

...University of South Carolina are building mitochondrial antibody assays for LMRA (see BioCentury, May 7). Lumera Corp....
BioCentury | Aug 20, 2007
Company News

Lumera management update

Lumera Corp. (LMRA), Bothell, Wash. Business: Supply/Service, Microarrays Resigned: Tom Mino as CEO and a director; Joseph Vallner, a director, will become interim CEO and president WIR Staff...
BioCentury | Aug 13, 2007
Company News

Capnia management update

...as SVP of technology development Departed: CEO Joseph Vallner to become chairman and CEO of Lumera Corp....
BioCentury | Aug 7, 2007
Company News

Capnia names Mario CEO

...replaces Joseph Vallner, who departed to become chairman and CEO of the Plexera subsidiary of Lumera...
BioCentury | Jul 23, 2007
Company News

Lumera supply/service, microarrays news

...be promoted to president and COO of Plexara from director of the bioscience business unit. Lumera Corp....
BioCentury | May 7, 2007
Company News

Lumera, Medical University of South Carolina deal

...of mitochondrial proteins. LMRA has rights to commercialize resulting IP. Financial terms were not disclosed. Lumera Corp....
BioCentury | Mar 12, 2007
Company News

Lumera board of directors update

Lumera Corp. (LMRA), Bothell, Wash. Business: Supply/Service, Microarrays Appointed: C. James Judson, a director, as chairman; he replaces Bob Ratliffe, who will remain a director WIR Staff...
Items per page:
1 - 10 of 21